Actalent Clinical Services for United Therapeutics located in North Carolina
Pulmonary hypertension associated with interstitial lung disease (PH-ILD; Group 3), which is high blood pressure in the lungs due to inflammation and sometimes scarring in the lungs. TYVASO or TYVASO DPI can improve the ability to exercise.
United Therapeutics had been involved in several clinical trials for Tyvaso (treprostinil), particularly for pulmonary arterial hypertension (PAH). However, please note that the specific details of ongoing or recent clinical trials may have changed since then. To obtain the most up-to-date information on United Therapeutics’ clinical trials for Tyvaso, I recommend visiting the official website of United Therapeutics or consulting clinical trial databases such as ClinicalTrials.gov. These platforms provide comprehensive and current information on clinical trials, including study locations, eligibility criteria, and enrollment status.
Entos Pharmaceuticals/CLIMAFRICA CRO/CNRFP
Entos Pharmaceuticals, a Canadian biotechnology company, has been actively engaged in clinical trials for various therapeutic candidates, primarily focusing on its Fusogenix drug delivery platform. However, specific details about ongoing or recent clinical trials may have evolved since then.
To access the most current information regarding Entos Pharmaceuticals’ clinical trials, I recommend visiting their official website or consulting reputable clinical trial databases such as ClinicalTrials.gov. These resources provide comprehensive and up-to-date information on Entos Pharmaceuticals’ clinical trial activities, including study objectives, eligibility criteria, trial locations, and enrollment status. Additionally, contacting the company directly may offer insights into their ongoing research initiatives and clinical trial pipeline.
Phase I/II Study to Evaluate Safety, Tolerability, and Immunogenicity of a Prophylactic Plasmid DNA Vaccine Against SARS CoV 2 [Covigenix VAX 001/VAX-001-1b] in Healthy Adults 18 Years and Older.